Dosing recommendations based on population pharmacokinetics of tacrolimus in Mexican adult patients with kidney transplant-Reference-Cited by-同舟云学术

Dosing recommendations based on population pharmacokinetics of tacrolimus in Mexican adult patients with kidney transplant

Published:2018-10-31 Issue:3 Volume:124 Page:303-311
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Reséndiz‐Galván Juan Eduardo¹,Medellín‐Garibay Susanna Edith¹^ORCID,Milán‐Segovia Rosa del Carmen¹,Niño‐Moreno Perla del Carmen¹,Isordia‐Segovia Javier²,Romano‐Moreno Silvia¹^ORCID

Affiliation:

1. Faculty of Chemistry Sciences Autonomous University of San Luis Potosi Mexico

2. Central Hospital “Dr. Ignacio Morones Prieto” San Luis Potosi Mexico

Funder

Universidad Autónoma de San Luis Potosí

Consejo Nacional de Ciencia y Tecnología

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13138

Reference34 articles.

1. Tacrolimus therapeutic drug monitoring in Tunisian renal transplant recipients: Effect of post-transplantation period

2. The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension

3. New onset diabetes after transplantation (NODAT): an overview

4. Importance of hematocrit for a tacrolimus target concentration strategy

5. Pharmacogenetics of Immunosuppressant Polymorphism of CYP3A5 in Renal Transplant Recipients

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosing strategy of tacrolimus when co-administered with Wuzhi tablet in renal transplant recipients;Int. Journal of Clinical Pharmacology and Therapeutics;2024-08-19

2. Improving prediction of tacrolimus concentration using a combination of population pharmacokinetic modeling and machine learning in chinese renal transplant recipients;Frontiers in Pharmacology;2024-05-09

3. Individualized dosing algorithms for tacrolimus in kidney transplant recipients: current status and unmet needs;Expert Opinion on Drug Metabolism & Toxicology;2023-07-03

4. Important lack of difference in tacrolimus and mycophenolic acid pharmacokinetics between Aboriginal and Caucasian kidney transplant recipients;Nephrology;2022-06-29

5. Population Pharmacokinetic Evaluation with External Validation of Tacrolimus in Chinese Primary Nephrotic Syndrome Patients;Pharmaceutical Research;2022-06-01